With respect to the relationship between CDKN2A and ferroptosis, studies have shown that loss of CDKN2A in GBM leads to remodeling of lipid metabolism, with oxidizable PUFAs redistributed into distinct lipid compartments. Here, CDKN2A is linked to glioblastoma.